mass spectrometry raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-07-08. Anything still debated is marked as such rather than presented as settled.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Typical form for short synthetic peptides |
| Solubility class | Freely soluble in water and aqueous buffer | Dissolution aided by gentle mixing, not vigorous shaking |
| Typical storage temperature | −20 °C, desiccated | −80 °C used for long-term holding |
| Common analytical method | Reverse-phase HPLC with UV detection near 214 nm | Identity confirmed separately by mass spectrometry |
| Common synonyms | Thymosin beta-4 fragment; TB4 fragment | Naming varies between suppliers and publications |
The seven-residue chain carries several polar and charged side chains, so it dissolves readily in water and in aqueous buffers near neutral pH. No cysteine is present, so disulphide formation is not a concern and reducing agents are unnecessary. Dilute ammonium hydroxide or acetonitrile-water mixtures are sometimes used for stock solutions when initial dissolution is slow. Strongly alkaline conditions and prolonged contact with oxidising agents are avoided because they can modify lysine-containing stretches, and haze in solution usually signals incomplete dissolution or aggregated material.
Identity and purity are checked with reversed-phase high-performance liquid chromatography, which separates the target sequence from truncated or deletion analogues, and with mass spectrometry, which confirms the expected molecular mass. Amino acid analysis and peptide mapping give orthogonal confirmation but are used less often outside specialist laboratories. Counter-ion content varies: material purified on trifluoroacetic acid gradients retains trifluoroacetate, and ion exchange can convert the salt form. Residual water and solvent are measured by Karl Fischer titration or thermogravimetric analysis, and any purity figure should be read together with the method used to obtain it.
Lyophilised peptide powders are hygroscopic, and the fragment absorbs atmospheric moisture when a vial is opened at room temperature. Weighing and aliquoting are normally done quickly in a dry environment, and stock solutions are divided into single-use portions before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and can shift the measured content of a vial. These practices are general to synthetic peptides rather than unique to this sequence, but they matter more for short chains kept for long periods.
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.
Research peptides are typically supplied as a white to off-white lyophilised powder in a sealed vial. The dry solid is more stable than a solution and is normally kept refrigerated or frozen until use. Dissolution is usually done in water, phosphate-buffered saline or a similar aqueous medium, depending on the assay. Because the material is hygroscopic and easily contaminated, opening vials in a low-humidity environment and recording the lot number before use are standard laboratory practices.
Once in solution, short peptides are generally less stable than the dry powder, and repeated freeze-thaw cycles are a common cause of loss. Laboratory guidance usually calls for aliquoting on first dissolution and storing aliquots at -20 °C or below, away from light. Adsorption to plastic and glass surfaces can lower measured concentration, particularly at low concentrations, so container material and buffer choice can affect results. Visible cloudiness, colour change or unexpected precipitate is a signal to re-check the material.
Purity is normally assessed by reversed-phase HPLC, with the main peak reported as a percentage of total peak area, while identity is confirmed by mass spectrometry. Electrospray and MALDI-TOF instruments are both used, and the observed mass is compared with the value calculated from the stated sequence. Ion-exchange or size-exclusion methods appear where aggregation or charge variants are of interest. Water content, counter-ion content and residual trifluoroacetate from purification are separate variables that can shift the measured mass and should be weighed when reading a certificate of analysis.
=== Ferdinand Schwarzwald === Ferdinand Schwarzwald (Nico Rogner) is the CFO of family-owned Austrian bank IBN Bauer, and a director on the board of Tender, in which his bank has a 6% stake. He backs Whitney's vision for pivoting the company away from pornography and gambling clients and into banking, and cautions Whitney that his co-founder and CEO Jonah Atterbury is "not a serious person", contributing to Jonah's eventual removal from the company. Ferdinand later helps Whitney and new Tender CEO Henry Muck execute a merger with IBN Bauer, traveling with them to Vienna to assuage the concerns of family heir Moritz-Hunter Bauer. He and Whitney also procure a billion-dollar investment from Al-Mi'raj Pierpoint during the release of Tender's banking app. Ferdinand is later revealed to be Whitney's handler on behalf of Russian foreign intelligence, having been recruited years ago by Cozy Bear (the hacker group affiliated with the FSB and SVR) and installed as IBN Bauer's CFO after stealing client lists that Russia could use as leverage. Amid public revelations of Tender's fraudulent profits out of Africa, Ferdinand warns Whitney that their narrative must remain intact, and implies that the Russians can assassinate anyone who goes "off-message". Ferdinand and fixer Dez Watkins later catch Whitney trying to disappear via New York and intercept him, forcing him to proceed with a hostile takeover bid for Pierpoint as it would represent a valuable "data set" for Russia.
As the price of bitcoin rose to $44,000 in December 2023, Bukele announced that El Salvador's investment into bitcoin had broken even. In March 2024, he stated that El Salvador had made a 50-percent profit from bitcoin. Bukele mocked news-media outlets on Twitter, saying that there were "literally thousands of articles" about El Salvador's bitcoin losses and the same outlets were now "totally silent". By 19 January 2025, the Salvadoran government had 6,043 bitcoins worth $611.2 million. In November 2021, Bukele announced that he planned to build Bitcoin City in the southeastern region of La Unión at the base of the Conchagua volcano. The city would use geothermal energy to power bitcoin mining. Ricardo Navarro, head of the Salvadoran Center of Appropriate Technology, criticized the plan, adding that it would result in an "environmental disaster". Bukele published images of models of Bitcoin City and its planned airport on Twitter in May 2022, saying that the city would have "no income tax, zero property tax, no procurement tax, zero city tax, and zero CO2 emissions". In December 2023, the Legislative Assembly passed a law that allowed individuals to purchase Salvadoran citizenship by donating bitcoins to El Salvador. On 18 December 2024, the International Monetary Fund (IMF) agreed to give El Salvador a $1.4 billion loan in exchange for the Salvadoran government making some concessions from the Bitcoin Law.
Alongside the general election, voters were asked to participate in a referendum regarding a proposed rewrite of the country's 2017 Constitution. On election night, unofficial results reported by Al Jazeera indicated that more than 57 per cent of voters had supported the drafting of a new constitution. People's Party leader Natthaphong Ruengpanyawut acknowledged that the referendum appeared to have been approved and stated his party would respect the parliamentary process. The proposal was carried. According to the Election Commission, 21,621,638 voters (60.16 per cent) approved the drafting of a new constitution, 11,241,653 (31.28 per cent) rejected it and 3,074,330 (8.55 per cent) expressed no opinion, from 35,937,621 valid ballots. A further 932,583 ballots were rejected as invalid. Turnout in the referendum was 36,870,266, or 69.65 per cent, about 937,000 fewer ballots than were cast in the general election held the same day. Support was broadly spread, with 288 of the 400 constituencies recording a 'yes' vote above 70 per cent and only 38 recording a 'no' vote above 50 per cent, two of them in Buriram and the remaining 36 in the upper south.
Sources: en.wikipedia.org
Andaman and Nicobar Islands Laccadive, Minicoy & Amindivi Islands (later renamed Lakshadweep) Delhi Manipur Tripura Himachal Pradesh By the early 1970s, Manipur, Tripura, and Himachal Pradesh had become full-fledged states, and Chandigarh became a union territory. Another three (Dadra and Nagar Haveli, Daman and Diu and Puducherry) were formed from acquired territories that were formerly part of Portuguese India and French India. In August 2019, the Parliament of India passed Jammu and Kashmir Reorganisation Act, 2019. The act contains provisions to reconstitute the state of Jammu and Kashmir into two union territories, one to be eponymously called Jammu and Kashmir, and the other Ladakh on 31 October 2019. In November 2019, the Government of India introduced legislation to merge the union territories of Dadra and Nagar Haveli and Daman and Diu into a single union territory to be known as Dadra and Nagar Haveli and Daman and Diu.
== Expression == In vertebrates, the olfactory receptors are located in both the cilia and synapses of the olfactory sensory neurons and in the epithelium of the human airway. Sperm cells also express odorant receptors, which are thought to be involved in chemotaxis to find the egg cell.
== March 2013 reconstitution == Following the return of the government at the 2013 state election, held on 9 March, the Ministry was again reconstituted, and was sworn in on 21 March 2013. John Castrilli (Local Government; Heritage; Citizenship and Multicultural Interests) and the retiring Norman Moore (Mines and Petroleum; Fisheries; Electoral Affairs) both resigned their positions, while Simon O'Brien (Finance; Commerce; Small Business), Robyn McSweeney (Child Protection; Community Services; Seniors and Volunteering; Women's Interests; Youth), and Murray Cowper (Training and Workforce Development; Corrective Services) each lost their portfolios. Five new ministers were appointed, including four previous parliamentary secretaries, and seven new parliamentary secretaries were appointed, making eight in total. A new portfolio, that of Minister for Veterans, was created. The list below is ordered by decreasing seniority within the Cabinet, as indicated by the Government Gazette and the Hansard index. Blue entries indicate members of the Liberal Party, while green entries indicate members of the National Party.
==== Vitamin C ==== Ascorbic acid or vitamin C, an oxidation-reduction (redox) catalyst found in both animals and plants, can reduce, and thereby neutralize, ROS, such as hydrogen peroxide. In addition to its direct antioxidant effects, ascorbic acid is also a substrate for the redox enzyme ascorbate peroxidase, a function that is used in stress resistance in plants. Ascorbic acid is present at high levels in all parts of plants and can reach concentrations of 20 millimolar in chloroplasts.
Sources: en.wikipedia.org
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.
Not necessarily. Some vendors use the name for the full 43-residue protein, while others apply it to a short actin-binding fragment or to a related tetrapeptide. The sequence should be confirmed from documentation rather than assumed from the label.
No thymosin beta-4 fragment holds marketing approval as a medicine in major jurisdictions. Material offered for sale is typically labelled for laboratory research only.
Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.